The Food and Drug Administration Friday revoked its emergency use authorization for Battelle Memorial Institute’s decontamination system for N95 respirators at Battelle's request.

“In response to changing customer needs, as of March 31, 2021, Battelle has ceased all Battelle CCDS decontamination site operations and marketing activities,” FDA said.

On April 9, FDA urged health care facilities to transition away from using crisis capacity conservation strategies such as decontamination or bioburden reduction to extend the use of N95s and other similar disposable respirators due to an increased domestic supply of new respirators.

Related News Articles

Headline
The U.S. Court of Appeals for the District of Columbia Circuit Friday reversed a 2018 district court decision in favor of UnitedHealth Group, rejecting the…
Headline
The Centers for Medicare & Medicaid Services today released a proposed rule that would rescind its November 2020 Most Favored Nation model interim final…
Headline
The Food and Drug Administration today approved a naloxone hydrochloride nasal spray to treat opioid overdoses that delivers 8 milligrams of naloxone, up from…
Blog
The mission of all hospitals and health systems, regardless of size and type of ownership, is to care for their communities and patients. In fact, an Ernst and…
Headline
The Centers for Medicare & Medicaid Services Friday released a toolkit for qualified health plans applying for plan year 2022 certification, and…
Headline
New information sharing requirements for health information technology take effect April 5 under an interim final rule released last year by the Office of the…